Your browser doesn't support javascript.
loading
Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Hu, Jie Hong; Touch, Phanith; Zhang, Jingwan; Wei, Hao; Liu, Shihui; Lund, Ida K; Høyer-Hansen, Gunilla; Dichek, David A.
Affiliation
  • Hu JH; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Touch P; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Zhang J; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Wei H; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Liu S; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lund IK; The Finsen Laboratory, Copenhagen University Hospital and Biotech Research & Innovation Centre, Copenhagen University, Copenhagen, Denmark.
  • Høyer-Hansen G; The Finsen Laboratory, Copenhagen University Hospital and Biotech Research & Innovation Centre, Copenhagen University, Copenhagen, Denmark.
  • Dichek DA; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA ddichek@uw.edu.
Cardiovasc Res ; 105(3): 372-82, 2015 Mar 01.
Article in En | MEDLINE | ID: mdl-25616415

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aorta / Aortic Diseases / Urokinase-Type Plasminogen Activator / Serine Proteinase Inhibitors / Atherosclerosis / Matrix Metalloproteinase Inhibitors Limits: Animals Language: En Journal: Cardiovasc Res Year: 2015 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aorta / Aortic Diseases / Urokinase-Type Plasminogen Activator / Serine Proteinase Inhibitors / Atherosclerosis / Matrix Metalloproteinase Inhibitors Limits: Animals Language: En Journal: Cardiovasc Res Year: 2015 Type: Article Affiliation country: United States